AI in bioinformatics has numerous applications, such as genomic sequence analysis, protein structure prediction, and drug discovery. Its features include machine learning algorithms for data interpretation, pattern recognition, and predictive modeling. AI helps identify disease biomarkers, optimize drug candidates, and personalize treatment plans. Additionally, it enables data integration from diverse sources, automates routine tasks, and accelerates research, fostering breakthroughs in Genomics, proteomics, and personalized medicine. AI's versatility and efficiency make it a powerful tool in advancing bioinformatics, revolutionizing healthcare and life sciences.
Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-ai-in-bioinformatics-market
Data Bridge Market Research analyses that the North America AI in Bioinformatics Market is valued at USD 995.94 million in 2021 and is expected to reach USD 19,677.40 million by 2029, registering a CAGR of 45.2% during the forecast period of 2022 to 2029. AI in bioinformatics allows the seamless integration of individual genomic and clinical data, creating a comprehensive understanding of a patient's unique genetic makeup and medical history. This integration enables personalized medicine approaches, tailoring treatments to each patient's specific needs, resulting in more precise and effective medical interventions, thus driving the market.
Key Findings of the Study
Automation and efficiency are expected to drive the market's growth rate
AI in bioinformatics automates various routine tasks such as data processing, annotation, and analysis, increasing researchers' efficiency. By leveraging machine learning algorithms, AI systems can quickly analyze vast amounts of biological data, accelerating scientific discoveries. Researchers can focus on interpreting results and generating insights rather than spending excessive time on manual tasks. This streamlined process expedites the pace of research, fostering more rapid advancements in the field of bioinformatics and contributing to the development of innovative healthcare solutions.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Offering (Services, Software, and Others), Type (Machine Learning, Deep Learning, and Others), Product and Services (Bioinformatics Services, Bioinformatics Platforms, and Knowledge Management Tools), Application (Genomics, Chemoinformatics & Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
|
Market Players Covered
|
JADBio & Gnosis Data Analysis (U.S.), SOPHiA GENETICS (Switzerland), Biomax Informatics AG (Germany), DNASTAR (U.S.), Ardigen (Poland), QIAGEN (Germany), Source BioScience (U.K.), NeoGenomics Laboratories (U.S.), Eurofins Scientific (Luxembourg), Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), CelbridgeScience (Ireland), Dassault Systemes (France), Fios Genomics (U.K.), Insilico Medicine (U.S.), Strand Life Sciences (India), Paige AI, Inc. (U.S.), SomaLogic, Operating Co., Inc. (U.S.), iNDX. Ai (India), Elucidata (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The North America AI in bioinformatics market is segmented on the basis of offering, type, product and services, application, and sector.
- On the basis of offering, the North America AI in bioinformatics market is segmented into services, software, and others.
- On the basis of type, North America AI in bioinformatics market is segmented into machine learning, deep learning, and others.
- On the basis of product and services, the North America AI in bioinformatics market is segmented into bioinformatics services, bioinformatics platforms, and knowledge management tools.
- On the basis of the application, the North America AI in bioinformatics market is segmented into genomics, chemoinformatics & drug design, proteomics, DNA sequencing, system biology, transcriptomics, text mining, microarrays, metabolomics, and others.
- On the basis of the sector, the North America AI in bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and others.
Major Players
Data Bridge Market Research recognizes the following companies as the major North America AI in bioinformatics market players in North America AI in bioinformatics market are JADBio & Gnosis Data Analysis (U.S.), SOPHiA GENETICS (Switzerland), Biomax Informatics AG (Germany), DNASTAR (U.S.), Ardigen (Poland), QIAGEN (Germany), Source BioScience (U.K.)
Market Developments
- In September 2022, TechBio firm Elucidata recently secured USD 16 million in a Series A funding round, with Eight Roads Ventures leading the investment. The capital will be used to bolster product capabilities in translational drug research and related sectors. Additionally, the funds will aid in expanding go-to-market efforts and facilitate global operational growth for the company.
- In January 2022, In a strategic collaboration, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, a prominent healthcare group in China, and Insilico Medicine, an AI-driven drug discovery company, joined forces to advance drug discovery and development targeting multiple global targets through AI technology. This partnership has facilitated an expansion of the company's product portfolio and increased its global reach and presence in the pharmaceutical market.
Regional Analysis
Geographically, the countries covered in the North America AI in bioinformatics market report are U.S., Canada and Mexico in North America.
As per Data Bridge Market Research analysis:
U.S. is the dominant region in North America AI in bioinformatics market during the forecast period 2022 - 2029
In 2022, U.S. dominated the North America AI bioinformatics market due to prominent universities and research institutions having played a pivotal role in advancing this field, with a particular focus on integrating AI techniques. These institutions have made substantial contributions through cutting-edge research, developing innovative algorithms, and applying AI for genomic analysis, drug discovery, and personalized medicine. The synergy between top-tier research centers and AI advancements has accelerated breakthroughs, leading to more profound insights into biological systems and new avenues for addressing complex healthcare challenges.
For more detailed information about the North America AI in bioinformatics market report, click here – https://www.databridgemarketresearch.com/reports/north-america-ai-in-bioinformatics-market
